Additionally, CCN2 expression was higher in colorectal adenocarcinoma (COAD) tissues than in normal tissues across various clinicopathological features, including sex, nodal metastasis, and TP53 mutation status (Figure 2C). This evidence concerns the gene TP53 and colon adenocarcinoma.